Compile Data Set for Download or QSAR
maximum 50k data
Found 127 with Last Name = 'scanlon' and Initial = 'ij'
TargetCarboxypeptidase G2(Pseudomonas aeruginosa)
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50171504((S)-2-{4-[Bis-(2-chloro-ethyl)-amino]-2,3,5,6-tetr...)
Affinity DataKi:  1.27E+5nMAssay Description:Inhibitory activity against carboxypeptidase G2 from pseudomonas RS16More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase G2(Pseudomonas aeruginosa)
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50171496((S)-2-{4-[Bis-(2-iodo-ethyl)-amino]-2,3,5,6-tetraf...)
Affinity DataKi:  2.76E+5nMAssay Description:Inhibitory activity against carboxypeptidase G2 from pseudomonas RS16More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180334(2-(3,4-Methylenedioxyphenylamino)-6-(3-acetamidoph...)
Affinity DataIC50:  32nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM16673(4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamo...)
Affinity DataIC50:  43nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM16673(4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamo...)
Affinity DataIC50:  46nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25616(2,6-Disubstituted Pyrazine, 79 | N-{4-[(6-{[3-(1,3...)
Affinity DataIC50:  310nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25612(2,6-Disubstituted Pyrazine, 70 | N-[5-({6-[(3,4,5-...)
Affinity DataIC50:  410nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180359(2-(3-Oxo-1,3-dihydroisobenzofuran-5-ylamino)-6-(3-...)
Affinity DataIC50:  490nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25613(2,6-Disubstituted Pyrazine, 76 | N-[4-({6-[(3,4,5-...)
Affinity DataIC50:  560nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25614(2,6-Disubstituted Pyrazine, 77 | N-{5-[(6-{[3-(1,3...)
Affinity DataIC50:  650nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180359(2-(3-Oxo-1,3-dihydroisobenzofuran-5-ylamino)-6-(3-...)
Affinity DataIC50:  740nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180350(2-[3-(Oxazol-5-yl)phenylamino]-6-(3-acetamidopheny...)
Affinity DataIC50:  790nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180353(2-(2,6-Dichloropyridin-4-ylamino)-6-(3-acetamidoph...)
Affinity DataIC50:  950nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25570(2,6-Disubstituted Pyrazine, 13 | 4-{6-[(3,4,5-trim...)
Affinity DataIC50:  1.10E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25580(2,6-Disubstituted Pyrazine, 26 | 6-(naphthalen-1-y...)
Affinity DataIC50:  1.20E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25569(1-phenyl-3-(4-{6-[(3,4,5-trimethoxyphenyl)amino]py...)
Affinity DataIC50:  1.20E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180339(2-(3,4-Dimethoxyphenylamino)-6-(3-acetamidophenyl)...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25609(2,6-Disubstituted Pyrazine, 73 | 6-{[(1E)-1-(hydro...)
Affinity DataIC50:  1.40E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180330(2-(3-Chlorophenylamino)-6-(3-acetamidophenyl)pyraz...)
Affinity DataIC50:  1.40E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25590(2,6-Disubstituted Pyrazine, 53 | 6-(quinolin-4-ylo...)
Affinity DataIC50:  1.50E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180354(2-(4-Morpholinophenylamino)-6-(3-acetamidophenyl)p...)
Affinity DataIC50:  2.30E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25615(2,6-Disubstituted Pyrazine, 78 | N-[5-({6-[(3-oxo-...)
Affinity DataIC50:  2.50E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180331(2-(3,5-Dimethoxyphenylamino)-6-(3-acetamidophenyl)...)
Affinity DataIC50:  2.70E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25562(2,6-Disubstituted Pyrazine, 4 | 6-(pyridin-4-yl)-N...)
Affinity DataIC50:  2.90E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180331(2-(3,5-Dimethoxyphenylamino)-6-(3-acetamidophenyl)...)
Affinity DataIC50:  3.00E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180337(2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-ylamino)-6-(3-...)
Affinity DataIC50:  3.00E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25568(2,6-Disubstituted Pyrazine, 10 | 4-{6-[(3,4,5-trim...)
Affinity DataIC50:  3.00E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180356(2-(3,4-Dihydro-2H-benzo[b][1,4]dioxepin-7-ylamino)...)
Affinity DataIC50:  3.30E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM25561(2,6-Disubstituted Pyrazine, 1 | CHEMBL200114 | N-(...)
Affinity DataIC50:  3.50E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25561(2,6-Disubstituted Pyrazine, 1 | CHEMBL200114 | N-(...)
Affinity DataIC50:  3.50E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM25561(2,6-Disubstituted Pyrazine, 1 | CHEMBL200114 | N-(...)
Affinity DataIC50:  3.60E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25593(2,6-Disubstituted Pyrazine, 56 | 6-(isoquinolin-5-...)
Affinity DataIC50:  3.80E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180332(2-(3,4-Methylenedioxyphenylaminomethyl)-6-(3-aceta...)
Affinity DataIC50:  3.80E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180358(2-[3-(2-Aminoethoxy)phenylamino]-6-(3-acetamidophe...)
Affinity DataIC50:  3.80E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25564(2,6-Disubstituted Pyrazine, 6 | 3-{6-[(3,4,5-trime...)
Affinity DataIC50:  4.00E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180341(2-(3-Methoxyphenylamino)-6-(3-acetamidophenyl)pyra...)
Affinity DataIC50:  4.00E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180333(2-[(5-Methyl-3-isoxazolyl)methylamino]-6-(3-acetam...)
Affinity DataIC50:  4.20E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180356(2-(3,4-Dihydro-2H-benzo[b][1,4]dioxepin-7-ylamino)...)
Affinity DataIC50:  4.50E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25575(2,6-Disubstituted Pyrazine, 21 | 2-N-(pyridin-4-yl...)
Affinity DataIC50:  4.70E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180341(2-(3-Methoxyphenylamino)-6-(3-acetamidophenyl)pyra...)
Affinity DataIC50:  4.80E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25577(2,6-Disubstituted Pyrazine, 23 | 4-({6-[(3,4,5-tri...)
Affinity DataIC50:  4.90E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180355(2-[4-(Trifluoromethoxy)phenylamino]-6-(3-acetamido...)
Affinity DataIC50:  5.20E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180358(2-[3-(2-Aminoethoxy)phenylamino]-6-(3-acetamidophe...)
Affinity DataIC50:  5.20E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180337(2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-ylamino)-6-(3-...)
Affinity DataIC50:  5.40E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25604(2,6-Disubstituted Pyrazine, 67 | N-[4-({6-[(3,4,5-...)
Affinity DataIC50:  5.50E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM16673(4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamo...)
Affinity DataIC50:  6.10E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180339(2-(3,4-Dimethoxyphenylamino)-6-(3-acetamidophenyl)...)
Affinity DataIC50:  6.40E+3nMAssay Description:Growth inhibition in human melanoma cells WM266.4 expressing mutant B-RAF with SRBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25587(2,6-Disubstituted Pyrazine, 32 | 6-(1H-indol-4-ylo...)
Affinity DataIC50:  7.40E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180352(2-(Phenylamino)-6-(3-acetamidophenyl)pyrazine | CH...)
Affinity DataIC50:  7.90E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf(Homo sapiens (Human))
Institute Of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50180344(2-(3-Fluorophenylmethylamino)-6-(3'-acetamidopheny...)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibitory activity against human B-RAFMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 127 total ) | Next | Last >>
Jump to: